KalVista Pharmaceuticals Inc. (KALV)
Market Closed
3 Jun, 20:00
$
26. 95
+0.01
+0.04%
$
1.43B Market Cap
- P/E Ratio
- Div Yield
6,429,095 Volume
-2.92 Eps
$ 26.94
Previous Close 
Want to track KALV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
KalVista Pharmaceuticals Inc. (KALV) Statistics
Valuation metrics
Market Cap 1.43B
Enterprise value 1.43B
Trailing P/E (ttm) -7.26
Forward P/E 22.4
PEG ratio 0.14
Price/Sales (ttm) 12.47
Price/Book (mrq) -74.44
Enterprise Value/Revenue 12.46
Enterprise Value/EBITDA -10.3
Overview
Shares outstanding 51.24M
Float 33.25M
Shares short 15.16M
% Held by insiders 0.02%
% Held by institutions 1.37%
Average volume (10 days) 3.83M
Average volume (90 days) 5.3M
Price summary
52-Week low 9.83
52-Week high 26.98
Beta -0.12
50-Day moving average 21.15
200-Day moving average 15.79
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:14
Last split Date 22 Nov 2016
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -1.19%
Operating margin -0.57%
Operational effectiveness
Return on assets -0.55%
Return on equity 67.67%
Income Statement
Revenue (ttm) 114.48M
Revenue per share (ttm) 2.11
Quarterly revenue growth (yoy) 1.98%
Gross profit (ttm) 58.47M
EBITDA -138.45M
Net income to common (ttm) -135.94M
Diluted EPS (ttm) -3.94
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 285.03M
Total cash per share (mrq) 5.35
Total debt (mrq) 284.31M
Total Debt/Equity (mrq) -14.47
Current ratio (mrq) 5.17%
Book value per share (mrq) -0.05
Cash Flow
Cash flow statement -89.32M
Levered free cash flow (LFCF) -183.44M
